Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of pro-apoptotic protein BTG2 via down regulation of its target gene, 13/April/2014, 8.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com
* Research cooperation